← Back to Search

Behavioral Intervention

Eccentric Exercise for Sarcopenia (ARMS-II Trial)

N/A
Waitlist Available
Led By Michael Harris-Love, DSc MPT BS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at study baseline for all subjects
Awards & highlights

ARMS-II Trial Summary

This trial is testing a new way to use ultrasound to screen for muscle conditions and a new type of exercise to help people with those conditions.

ARMS-II Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at study baseline for all subjects, and at week 6 and 12 of the intervention period for subjects randomly assigned to an exercise group
This trial's timeline: 3 weeks for screening, Varies for treatment, and at study baseline for all subjects, and at week 6 and 12 of the intervention period for subjects randomly assigned to an exercise group for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline in Sonographic Lean Body Mass at 3 months
Secondary outcome measures
Change from Baseline in dual-energy X-ray absorptiometry (DXA) scanning at 3 months
Adipose tissue
Change from Baseline in metabolic status at 3 months
+1 more

ARMS-II Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Eccentric ExerciseExperimental Treatment1 Intervention
Supervised strengthening exercise using eccentric muscle actions.
Group II: Concentric ExerciseActive Control1 Intervention
Supervised strengthening exercise using concentric muscle actions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Eccentric Exercise
2009
N/A
~150

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,317 Total Patients Enrolled
3 Trials studying Sarcopenia
263 Patients Enrolled for Sarcopenia
Michael Harris-Love, DSc MPT BSPrincipal InvestigatorRocky Mountain Regional VA Medical Center, Aurora, CO
1 Previous Clinical Trials
1 Trials studying Sarcopenia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment currently open for this research endeavor?

"Clinicaltrials.gov reports that enrolment for this medical trial is currently closed, having been posted on March 1st 2015 and last updated February 16th 2022. However, there are 107 other clinical trials recruiting participants at present."

Answered by AI

Is the target population of this research endeavor restricted to individuals over fifty years old?

"The eligibility requirements for participation in this trial specify that, at a minimum, individuals must be 18 years old and cannot exceed 85 years of age."

Answered by AI

Does my medical background enable me to partake in this trial?

"This clinical trial demands that participants must suffer from sarcopenia and be between 18-85 years old. The research team are recruiting 136 patients in total."

Answered by AI
Recent research and studies
~13 spots leftby Apr 2025